Literature DB >> 15162479

Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function.

Ronnie T Poon1, Sheung Tat Fan.   

Abstract

Entities:  

Year:  2004        PMID: 15162479     DOI: 10.1002/lt.20175

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  8 in total

1.  Recent advances and controversies in surgical management of liver diseases: summary of liver sessions of 7th World Congress of IHPBA 2006.

Authors:  Ronnie T P Poon
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

2.  Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.

Authors:  Balkrishan Sharma; Radhika Srinivasan; Yogesh Kumar Chawla; Shweta Kapil; Nitin Saini; Bhupesh Singla; Anuradha Chakraborthy; Naveen Kalra; Ajay Duseja; Radha Krishan Dhiman
Journal:  Hepatol Int       Date:  2010-07-13       Impact factor: 6.047

3.  Resection and liver transplantation for HCC.

Authors:  Jacques Belghiti
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

4.  Chemopreventive effect of 18β-glycyrrhetinic acid via modulation of inflammatory markers and induction of apoptosis in human hepatoma cell line (HepG2).

Authors:  Syed Kazim Hasan; Aisha Siddiqi; Sana Nafees; Nemat Ali; Summya Rashid; Rashid Ali; Ayaz Shahid; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2016-04-26       Impact factor: 3.396

5.  Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells.

Authors:  Y Xie; W Sheng; J Miao; J Xiang; J Yang
Journal:  Cancer Gene Ther       Date:  2010-11-05       Impact factor: 5.987

6.  Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC.

Authors:  Zhenhua Hu; Qijun Zhang; Jie Zhou; Zhiwei Li; Jie Xiang; Lin Zhou; Jian Wu; Min Zhang; Shusen Zheng
Journal:  BMJ Open       Date:  2015-09-09       Impact factor: 2.692

7.  Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.

Authors:  Lai-Chun Ong; In-Chin Song; Yi Jin; Irene H C Kee; Eeyan Siew; Sidney Yu; Choon-Hua Thng; Hung Huynh; Pierce K H Chow
Journal:  Mol Imaging Biol       Date:  2009-03-28       Impact factor: 3.488

8.  Apoptotic and inhibitory effects on cell proliferation of hepatocellular carcinoma HepG2 cells by methanol leaf extract of Costus speciosus.

Authors:  Sandhya V G Nair; Menik Hettihewa; H P Vasantha Rupasinghe
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.